Adial Pharmaceuticals Inc (NASDAQ:ADIL)

Adial Pharmaceuticals Inc (NASDAQ:ADIL)

Share Price
$ 3.01
-0.3 (-9.06 %)
Market Cap
$30.32 m
Proactive Investors - Run By Investors For Investors

Adial Pharmaceuticals Inc

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders in the United States. Its lead product is AD04, a selective serotonin-3 antagonist that has completed Phase IIb clinical trials for the treatment of nausea and emesis. The company was founded in 2010 and is based in...

52-week High/Low: $9.44 / $1.11
Sector: Health Care, Equipment & Services
Market Cap: $30.32 m
col 3
col 4
col 5
col 6

Adial Pharmaceuticals Inc Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use